Cobot orders surged 55.6% in Q1 2026 as automation demand shifts away from automotive OEMs

North American companies ordered 9,055 robots worth $543 million in the first quarter of 2026, a figure that looks stable on the surface but conceals a significant rebalancing underneath. According to data released by the Association for Advancing Automation (A3), unit orders slipped just 0.1% and revenue fell 6.4% compared to Q1 2025. Almost the entire decline traces to one segment: automotive original equipment manufacturers, whose robot orders dropped 35.1% in units and 48.2% in revenue year over year.

Strip out that automotive OEM drag, and the rest of the North American robotics market looks considerably healthier. Life sciences, semiconductors, food production, and general manufacturing all posted double-digit gains, and collaborative robots recorded their strongest quarterly growth in recent memory. The Q1 numbers, first reported by Industrial Equipment News citing A3's official release, suggest the industry's center of gravity is moving.

Automotive softness versus broad-based growth

The automotive OEM pullback is partly cyclical. Large vehicle programs place robot orders in concentrated bursts tied to model launches and retooling cycles, so a single quiet quarter can swing the aggregate figures sharply. Automotive component suppliers, which typically lag OEM ordering patterns, actually grew 28.1% in units and 15.5% in revenue during the same period, according to A3, reinforcing the view that the OEM dip reflects timing more than a structural retreat from automation.

The non-automotive story is harder to dismiss as cyclical. Life sciences, pharma, and biomedical companies increased robot orders 54.1% in units and 70.2% in revenue compared to Q1 2025. Semiconductors and electronics followed at 31.7% unit growth and a striking 79.2% revenue increase, a gap that signals buyers are selecting higher-value, more specialized systems. Plastics and rubber grew 25.2% in units, food and consumer goods rose 16.0%, and the catch-all "all other industries" category climbed 24.5% in units and 29.2% in revenue, per A3.

Collaborative robots cross a milestone

The collaborative robot category posted the quarter's most decisive numbers. Companies ordered 1,637 cobots valued at $69.8 million in Q1 2026, representing a 55.6% increase in units and a 78.2% jump in revenue compared to the same quarter last year, according to A3. Cobots now account for 18.1% of all robot units ordered in North America and 12.9% of total order revenue.

Adoption patterns by sector reveal where cobots are making the deepest inroads. In life sciences, pharma, and biomed, cobots represented 60.7% of all robot orders placed in the sector during the quarter. Semiconductors and electronics came in at 45.9%, and the broad "all other industries" bucket sat at 29.0%, per A3. These figures matter for operations leaders evaluating deployment models: cobots are no longer a supplementary option in those verticals; they are the primary automation vehicle.

A3 Executive Vice President Alex Shikany noted, as reported by Industrial Equipment News, that the cobot trend reflects broader evolution in how companies are approaching automation, with greater diversity in industries, applications, and deployment models. He characterized that diversity as a positive signal for the market's long-term resilience.

What the diversification signals for procurement and operations teams

The shift away from automotive concentration carries practical implications. For decades, robotics vendors and integrators organized their go-to-market strategies, their service networks, and their financing models around the rhythms of automotive OEM programs. A market where life sciences, electronics, and food producers are driving incremental volume demands different integrator relationships, different cell designs, and often different safety and regulatory certifications.

Labor availability continues to push non-automotive manufacturers toward automation. Supply chain resilience, quality consistency, and global competitiveness are recurring drivers cited in A3's reporting. For a VP of Operations in food processing or a procurement director sourcing capital equipment for a pharma facility, the Q1 data confirms that the vendor ecosystem is responding: more suppliers are building cobot-ready cells and application-specific solutions for regulated industries.

The semiconductor and electronics revenue jump of 79.2% on only 31.7% unit growth is also worth watching. It points to buyers selecting more sophisticated, higher-priced systems, likely driven by precision requirements in chip packaging, inspection, and assembly. That average-selling-price inflation means capital budgets in electronics automation are being stretched further than unit counts alone would suggest.

Looking at the rest of 2026

The A3 Automate 2026 conference, held in Chicago in late June, brought together automation suppliers and enterprise buyers at a moment when this diversification trend was front of mind across the industry. Whether the automotive OEM segment rebounds in Q2 and Q3 will depend largely on the pace of new platform retooling decisions, which in turn are tied to broader capital allocation timing at the major vehicle manufacturers.

For the non-automotive segments, the trajectory entering mid-2026 looks durable. The industries posting the strongest gains, life sciences, electronics, and food production, face structural pressures that do not resolve in a single quarter. If collaborative robot adoption continues at its Q1 pace, cobots could represent a quarter or more of all North American robot orders before the end of the year.